Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012

@article{Tong2014ProgressiveII,
  title={Progressive increase in community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations in northern Australia from 1993 to 2012},
  author={Steven Y. C. Tong and Liana Varrone and Mark D. Chatfield and Miles H Beaman and Phillip M Giffard},
  journal={Epidemiology and Infection},
  year={2014},
  volume={143},
  pages={1519 - 1523}
}
SUMMARY Hospital-based studies have determined high rates of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Indigenous populations. However, there is a paucity of community-based data. We obtained 20 years (1993–2012) of data on S. aureus isolates (N = 20 210) collected from community clinics that provide services for Indigenous communities in the Northern Territory, Australia. Methicillin resistance increased from 7% to 24%, resistance to macrolides remained stable… 
View on Cambridge Press
cambridge.org
40 Citations
Background Citations
5

40 Citations

Citation Type

Citation Type

The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia
TLDR
This is the first Australian report of CA-MRSA superseding MSSA as the cause of community onset staphylococcal SSTI, and the possibility of healthcare-associated transmission of CA -MRSA is suggested.
Changing epidemiology of community-associated methicillin-resistant Staphylococcus aureus in the Asia-Pacific region
  • K. Huh, D. Chung
  • Medicine, Biology
    Expert review of anti-infective therapy
  • 2016
TLDR
The molecular epidemiology of CA-MRSA in the Asia-Pacific region shows a marked diversity in each country, but some strains – multilocus sequence type (MLST) ST59, ST30, ST72, ST8, and ST772 – are unique clones that have successfully established themselves as predominant, often spreading into nosocomial settings.
Increasing prevalence of methicillin-resistant Staphylococcus aureus in remote Australian communities: implications for patients and clinicians.
Incidence of community onset MRSA in Australia: least reported where it is Most prevalent
TLDR
A standardized national reporting system in Australia is recommended that reports infections at a range of infection sites, has broad geographic coverage and consistent use of terminology, to improve surveillance and inform effective interventions.
Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.
TLDR
Community-associated MRSA is a common cause of skin and soft tissue infections and might be common in populations where overcrowding and limited access to clean water exist, and it retains susceptibility to some oral agents including trimethoprim-sulfamethoxazole, clindamycin, and tetracyclines.
Whole genome sequencing to investigate a putative outbreak of the virulent community-associated methicillin-resistant Staphylococcus aureus ST93 clone in a remote Indigenous community
TLDR
The proximity in time and space of the two severe pneumonia cases is probably a reflection of the high burden of disease due to ST93 MRSA in this population where skin infections and household crowding are common.
Antibiotic resistance in uropathogens across northern Australia 2007–20 and impact on treatment guidelines
TLDR
Antibiotic resistance in uropathogens is increasing in northern Australia, but treatment guidelines generally remain appropriate for empirical therapy of patients with suspected infection (except trimethoprim in some settings), demonstrating the importance of local surveillance data (HOTspots) to inform clinical decision making and guidelines.
The epidemiology of Staphylococcus aureus skin and soft tissue infection in the southern Barkly region of Australia's Northern Territory in 2017.
Clinical and Molecular Epidemiology of an Emerging Panton-Valentine Leukocidin-Positive ST5 Methicillin-Resistant Staphylococcus aureus Clone in Northern Australia
TLDR
Whole-genome sequence analysis demonstrates that ST5-MRSA-SCCmec IVo is causing a clonal outbreak across a large geographical region and is now the second most common community-associated MRSA clone in parts of Australia and causes a spectrum of clinical disease similar to that caused by the virulent ST93- MRSA lineage.
Molecular characterization of community‐associated methicillin‐resistant Staphylococcus aureus from pet dogs
TLDR
A high prevalence of human host‐adapted community‐associated MRSA carriage in dogs despite an absence of MRSP suggests MRSA carried by dogs in remote NSW originate from human hosts, and the cycle of transmission between people, dogs and common environmental sources warrants further investigation.
...
1
2
3
4
...

References

SHOWING 1-10 OF 13 REFERENCES
Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations.
TLDR
Molecular and epidemiological studies support the role of genetic transfer of resistance determinants (SCCmecIV) in the emergence of community-associated methicillin-resistant Staphylococcus aureus in Australia.
Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia.
Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes.
TLDR
The association ofnmMRSA infection with female sex and remote residence supports the hypothesis that nmMRSA arose from MSSA strains in remote Aboriginal communities where staphylococcal disease is highly prevalent and suggests that virulence is not correlated with resistance phenotype.
Waves of resistance: Staphylococcus aureus in the antibiotic era
TLDR
The molecular epidemiology of the epidemic waves of peniillin- and methicillin-resistant strains of S. aureus that have occurred since 1940 are reviewed, with a focus on the clinical and molecular epidemiological of CA-MRSA.
Adaptive Change Inferred from Genomic Population Analysis of the ST93 Epidemic Clone of Community-Associated Methicillin-Resistant Staphylococcus aureus
TLDR
The evolution of ST93 S. aureus is associated with a reduction in both exotoxin expression and oxacillin MIC, suggesting MRSA ST93 isolates are under pressure for adaptive change.
Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia.
TLDR
PVL was associated with truly community-acquired disease, younger age, and presentation with sepsis, and MSSA contributes a large but underrecognized burden of PVL(+) disease.
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?
TLDR
Clinical relevance of advances in the understanding of staphylococcal colonization, virulence, host susceptibility, and therapeutics is focused on.
Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
Skin disease in the first two years of life in Aboriginal children in East Arnhem Land
TLDR
This poster explains how Group A streptococcal skin infections are linked to the high rates of heart and renal disease occurring in Aboriginal Australians and how to identify and treat these infections.
...
1
2
...